Local Anesthesia Drugs Market Expected to Reach $4.7 Billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Local Anesthesia Drugs Market," The local anesthesia drugs market share was valued at $2.6 billion in 2021, and is estimated to reach $4.7 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031.

The local anesthesia drugs market is gaining significant popularity owing to its role in relieving pain without risks. This is because, these drugs only numb the body without making patient unconscious. Some of commonly used local anesthesia drugs include procaine, chloroprocaine, tetracaine, ropivacaine, lidocaine, bupivacaine, and mepivacaine. Articaine is another popular local anesthesia drug that is used in dentistry. Local anesthesia drugs helps in blocking the transmission of impulses to the nerve fibers that eliminates or reduces the feeling of sensation. The local anesthesia drugs are weak bases that exists in both charged and uncharged form. The use of local anesthesia drugs help the doctors in stitching up wound or taking biopsy without the feeling of pain. These factors are anticipated to boost the local anesthesia drugs market size in the upcoming years. 

The growing applications of local anesthesia drugs for skin biopsy, minor surgical procedures, or dental procedures is estimated to generate excellent growth opportunities. The local anesthesia drugs prevent pain caused to the patients during medical procedures. The effects of these drugs are short lived. Local anesthesia drugs are suitable for minor procedures and they can be used to relieve pain caused by cancer and bone or joint diseases. Also, local anesthesia drugs are safer than opioids. Local anesthesia drugs block nerves and prevent them from carrying pain signals. This nerve blockage saves the patient from feeling pain. Also, there is no need for anesthesiologist, as the doctors or surgeons can themselves give anesthesia before starting the procedure. The cost of local anesthesia drugs is quite low, patient can recover quickly, and dangers like aspiration pneumonia are less. These factors are predicted to propel the local anesthesia drugs market growth during the forecast period. 

Some of the side effects associated with local anesthesia drugs include soreness at the injection site, headache, nausea, ringing in the ears, and others. Some patients may also experience disturbances in blood pressure and heart rhythm. These factors are anticipated to restrain the local anesthesia drugs market opportunity in the coming years. 

Local anesthesia drugs offer relief for pain & itching owing to which it is used in various surgeries and medical procedures. For instance, these drugs can provide relief from cancer-related pain, joint pain especially pain in spine, open sores, rashes, and ivy contact. Also, they can be used in labor pain during which doctor may give epidural anesthesia to the pregnant women. In addition, diagnostic processes such as spinal tap & biopsy use local anesthesia drugs. The effect of local anesthesia goes off quickly. For instance, the effect of lignocaine which is widely used local anesthesia drug wears off in an hour. In order to prolong the effect of these drugs the healthcare professional may combine these drugs with epinephrine, steroids, or clonidine. The local anesthetic drugs can be delivered in three ways namely via local injection, local application, and nerve blocks. The drugs used for local application can be applied to mouth ulcers or open sores. These aspects are anticipated to boost the local anesthesia drugs industry demand in the forecast period. 

The local anesthesia drugs market is segmented on the basis of drugs type, application, and region. By drugs type, it is classified into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and other local anesthetics. As per application, the market is divided into injectable and surface anesthetic. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

The key players profiled in the local anesthesia drugs market report include Novartis AG, Aspen Pharmacare, Sagent Pharmaceuticals, Pacira Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi, Mylan N.V., GSK plc., AstraZeneca plc, and Hikma Pharmaceuticals plc. 

The report offers a comprehensive analysis of the global local anesthesia drugs market trends by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working toward the growth of the market. The report also highlights the present scenario and upcoming trends & developments that are contributing toward the growth of the market. Moreover, restraints and challenges that hold power to obstruct the market growth are also profiled in the report along with the Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and the emergence of substitutes in the market. 

Impact of COVID-19 on the Global Local Anesthesia Drugs Industry 

• The COVID-19 pandemic has created havoc across several industries owing to economic crisis and supply chain disruptions. However, the local anesthesia drugs market demand was moderately impacted during the pandemic. 

• The moderate impact of COVID-19 on local anesthesia drugs sales can be attributed to postponements or cancellations of non-essential surgeries as the priorities were given to the COVID-19 related health complications. 

• In addition, due to the fear of contracting COVID-19 virus most of the patients avoided or delayed their hospital visits for routine check-ups and minor surgeries. The patients who have taken COVID-19 vaccine were advised to wait at least for two weeks before undergoing any surgery. This is because anesthesia drugs may reduce the efficacy of the vaccine. 

• However, increase in hospitalization rate, increase in symptoms severity due to coronavirus, and body & joint pain have led to moderate increase in the demand for local anesthesia drugs. Thus, the impact of coronavirus on the local anesthesia drugs market size was moderate during the pandemic. 

Key Findings of the Study 

• Based on drugs type, the lidocaine sub-segment emerged as the global leader in 2021 and is anticipated to be the fastest growing segment during the forecast period. 

• Based on application, the injectable sub-segment emerged as the global leader in 2021 and surface anesthetic sub-segment is predicted to witness the fastest growth during the forecast period. 

• Region wise, the North America market registered the highest market share in 2021 and is projected to maintain its position during the forecast period.